Inactive Instrument

GeneNews Ltd Stock Toronto S.E.

Equities

CA36870T2065

Biotechnology & Medical Research

Sales 2021 5.07M 6.97M Sales 2022 3.8M 5.22M Capitalization 4.49M 6.18M
Net income 2021 -7M -9.62M Net income 2022 -11M -15.12M EV / Sales 2021 3.99 x
Net cash position 2021 368K 507K Net Debt 2022 1.78M 2.45M EV / Sales 2022 1.65 x
P/E ratio 2021
-2.2 x
P/E ratio 2022
-0.39 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 79.63%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 01-12-31
Investor Relations Contact - -
Members of the board TitleAgeSince
Founder 71 97-12-31
Director/Board Member 90 99-12-31
Chief Executive Officer - 01-12-31
More insiders
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.
More about the company